Parainfluenza virus 3 (PIV3) is a respiratory virus associated with severe childhood illnesses, particularly bronchiolitis and pneumonia. It is also known as human parainfluenza virus type 3 (HPIV3). PIV3 is a member of the Paramyxoviridae family, which includes other viruses such as measles, mumps, and respiratory syncytial virus (RSV). Despite its prevalence in the population, there is still much that is unknown about PIV3 and the diseases it causes. In this article, we will discuss the epidemiology, transmission, diagnosis, treatment, and prevention of PIV3.
PIV3 is a common virus, with an estimated 20-40% of all childhood respiratory illnesses being caused by it. It is most commonly seen in young children, with the highest incidence occurring in children between the ages of 6 months and 2 years. PIV3 is more common in the winter months, with peak activity occurring in December and January. It is also more common in certain geographical areas, such as the southeastern United States and in lower-income countries.
PIV3 is spread through contact with respiratory secretions, such as saliva, mucus, or nasal secretions. It is also spread through contact with surfaces or objects that have been contaminated with the virus. PIV3 is highly contagious and can be spread through coughing and sneezing.
The diagnosis of PIV3 is usually made based on clinical symptoms. However, laboratory tests can be used to confirm the diagnosis. These tests include polymerase chain reaction (PCR) tests, virus isolation, and serology tests.
There is no specific treatment for PIV3. Treatment is mainly supportive, and may include oxygen therapy, hydration, and medications to reduce fever and relieve symptoms. In severe cases, hospitalization may be necessary.
The best way to prevent PIV3 is to practice good hygiene. This includes washing hands often with soap and water, avoiding contact with people who are sick, and avoiding sharing items such as cups and utensils. Vaccines are also available to prevent PIV3, but they are not routinely recommended.
Parainfluenza virus 3 is a common virus that is associated with severe childhood illnesses. It is spread through contact with respiratory secretions and contaminated objects. Diagnosis is usually based on clinical symptoms, but laboratory tests can be used to confirm the diagnosis. Treatment is mainly supportive, and prevention is best achieved through good hygiene practices. Vaccines are available, but are not routinely recommended.
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
3.
Germline Profiling May Improve Risk Stratification in t-MNs
4.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
5.
Scientists call into question safety of potential new anticancer treatment
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
3.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Clinical Insights in Hematology
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Updates on the First Line Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation